Mektovi tablets 15mg, with the ingredient Binimetinib, are produced by Ono Pharmaceutical. This medication (YJ code: 4291058F1024, 15mg 1 tablet) is a MEK inhibitor used in combination with encorafenib to treat certain types of metastatic melanoma or non-small cell lung cancer (NSCLC) with specific BRAF mutations.
Mektovi tablets 15mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).